David Apple and Gerd Auffarth. The Apple Lab at the David J Apple Center for Vision Research in Heidelberg is a thriving international laboratory for research into intraocular devices. The lab continues the work of David J Apple, a world-renowned...
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.
COMPlog is software designed to replace physical Snellen and LogMAR charts. We have been using COMPlog since 2017 in the unit where I work. Some readers may find our experience, and reasons for choosing this product, interesting. This article is...
The objective of this study was to describe the changes in the retinal ganglion cell complex (GCC) relative to the retinal nerve fibre layer (RNFL) over time, in patients with Leber’s hereditary optic neuropathy (LHON). For this study, 21 patients...
The authors report the efficacy in preventing lower eyelid retraction and long-term results of a new technique of inferior rectus recession for vertical strabismus. The results for 35 patients were compared with 22 patients having conventional inferior rectus recession. Inferior...
The authors report a case series of 21 patients (41 eyes) diagnosed with acute methanol poisoning following an outbreak in Tunisia in 2020. All patients underwent a complete ophthalmological examination including visual fields, colour vision test and optical coherence tomography...
In a continuing look at wearable technology, for those with sight impairment, for Aug/Sep we are looking at the recently released ARx. In previous issues we have covered the Envision Glasses and the OrCam MyEye. The ARx is a device...
Retinopathy of prematurity (ROP) is a disorder of the immature preterm retina and a leading cause of preventable, irreversible blindness in children. There are 15 million preterm births annually, and over 32,000 neonates became blind from ROP in 2010 [1]....
Nearly 60,000 people in Scotland living with glaucoma could benefit from carrying out tests at home, a study funded by Sight Scotland and the Royal College of Surgeons of Edinburgh has shown.
“It’s been brilliant – I’d much rather have cataract surgery than visit the dentist!” Carol celebrates better vision as Wakefield Eye Hospital’s 20,000th patient.